Test Directory
3327 Anti-Mullerian Hormone (AMH)
Specimen Type
Specimen Stability
Reference Range
Serum-SST
7 days 2-8°C
Female: ng/mL
<14 yrs 0.30-11.21
20-29 yrs 0.65-16.40
30-39 yrs 0.16-8.43
40-49 yrs <5.20
>49 yrs <2.05
Male:
<1 yr 101.90-262.00
1- 6 yrs 87.30-243.80
7-11 yrs 34.30-230.10
12-17 yrs <135.45
>17 yrs 1.45-15.27
<14 yrs 0.30-11.21
20-29 yrs 0.65-16.40
30-39 yrs 0.16-8.43
40-49 yrs <5.20
>49 yrs <2.05
Male:
<1 yr 101.90-262.00
1- 6 yrs 87.30-243.80
7-11 yrs 34.30-230.10
12-17 yrs <135.45
>17 yrs 1.45-15.27
Specimen Requirements
Preferred amount: 1.0 mL Serum
Minimum amount: 0.5 mL Serum
Minimum amount: 0.5 mL Serum
Method
Enzyme Linked Immunosorbent Assay (ELISA)
Schedule
Tue, Thu, Sat
Turn-Around Time
1-3 Days
Instructions/Notes
Centrifuge required?: Yes
Clinical Utility
AMH levels are associated with ovarian reserve, evaluating fertility status, assessing abnormalities such as polycystic ovarian syndrome and ovarian tumors, and helping to predict the onset of menopause. AMH in males is involved in inhibiting the Mullerian ducts during fetal development and pathologically can result in persistent Mullerian duct syndrome and cryptorchidism. May be useful in evaluating infants with ambiguous genitalia. AMH remains present during childhood in males but drastically decreases during puberty.
CPT Codes
83520
